Product Images Lemtrada

This is a summary of a clinical study or trial investigating the effects of interferon beta-1a and LEMTRADA on patients over a certain follow-up period. It includes information such as the number of patients in the study, the p-value, and the number of months in the follow-up period. However, it is difficult to interpret without more context or additional information.*

Description: Each carton of LEMTRADA injection contains a single dose vial of alemtuzumab solution for intravenous infusion. The solution consists of alemtuzumab (10 mg), dibasic sodium phosphate (1.15 mg), sodium edetate dihydrate (0.0187 mg), polysorbate 80 (0.1 mg), potassium chloride (0.2 mg), potassium dihydrogen phosphate (0.2 mg), and sodium chloride (8 mg). It is used for single use only, and should be stored in the refrigerator at 2°C to 8°C (36°F to 46°F). The solution does not contain preservatives and should not be frozen or shaken. Each single dose vial must be discarded after use. Sanofi Genzyme is the manufacturer and distributor of LEMTRADA injection, with a US License No. 1596 injection origin from Germany. The dosage and administration information is available on the package insert. The text also includes a datamatrix code and a lot number.*